Eventide Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-164,299
| Closed | -$14.5M | – | 157 |
|
|
2023
Q3 | $14.5M | Hold |
164,299
| – | – | 0.26% | 103 |
|
|
2023
Q2 | $14.2M | Hold |
164,299
| – | – | 0.24% | 104 |
|
|
2023
Q1 | $16M | Sell |
164,299
-65,701
| -29% | -$6.39M | 0.29% | 94 |
|
|
2022
Q4 | $23.8M | Buy |
+230,000
| New | +$23.8M | 0.47% | 69 |
|
|
2018
Q4 | – | Sell |
-132,000
| Closed | -$12.8M | – | 140 |
|
|
2018
Q3 | $12.8M | Buy |
132,000
+57,000
| +76% | +$5.53M | 0.47% | 67 |
|
|
2018
Q2 | $7.07M | Hold |
75,000
| – | – | 0.29% | 86 |
|
|
2018
Q1 | $6.08M | Hold |
75,000
| – | – | 0.28% | 86 |
|
|
2017
Q4 | $6.69M | Hold |
75,000
| – | – | 0.35% | 77 |
|
|
2017
Q3 | $6.98M | Hold |
75,000
| – | – | 0.4% | 69 |
|
|
2017
Q2 | $6.81M | Hold |
75,000
| – | – | 0.42% | 61 |
|
|
2017
Q1 | $6.58M | Hold |
75,000
| – | – | 0.44% | 62 |
|
|
2016
Q4 | $6.21M | Hold |
75,000
| – | – | 0.4% | 63 |
|
|
2016
Q3 | $6.94M | Hold |
75,000
| – | – | 0.42% | 63 |
|
|
2016
Q2 | $5.84M | Hold |
75,000
| – | – | 0.36% | 68 |
|
|
2016
Q1 | $6.19M | Hold |
75,000
| – | – | 0.35% | 67 |
|
|
2015
Q4 | $7.86M | Sell |
75,000
-5,400
| -7% | -$566K | 0.39% | 65 |
|
|
2015
Q3 | $8.47M | Buy |
80,400
+28,600
| +55% | +$3.01M | 0.49% | 58 |
|
|
2015
Q2 | $7.09M | Buy |
51,800
+11,700
| +29% | +$1.6M | 0.38% | 65 |
|
|
2015
Q1 | $5M | Buy |
40,100
+9,900
| +33% | +$1.23M | 0.38% | 69 |
|
|
2014
Q4 | $2.73M | Hold |
30,200
| – | – | 0.3% | 70 |
|
|
2014
Q3 | $2.18M | Hold |
30,200
| – | – | 0.3% | 69 |
|
|
2014
Q2 | $1.88M | Buy |
30,200
+2,100
| +7% | +$131K | 0.26% | 78 |
|
|
2014
Q1 | $1.92M | Buy |
28,100
+17,700
| +170% | +$1.21M | 0.3% | 70 |
|
|
2013
Q4 | $731K | Buy |
+10,400
| New | +$731K | 0.23% | 68 |
|